Profile data is unavailable for this security.
About the company
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.
- Revenue in USD (TTM)771.65m
- Net income in USD-120.49m
- Incorporated2018
- Employees1.63k
- LocationOrthofix Medical Inc3451 Plano PkwyLEWISVILLE 75056-9453United StatesUSA
- Phone+1 (214) 937-2000
- Fax+1 (302) 636-5454
- Websitehttps://ir.orthofix.com/ir-home/default.aspx
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Varex Imaging Corp | 832.70m | 34.20m | 441.31m | 2.30k | 23.59 | 0.7586 | 6.49 | 0.530 | 0.4574 | 0.4574 | 16.46 | 14.22 | 0.6758 | 1.95 | 5.28 | 346,958.30 | 2.82 | 0.9913 | 3.33 | 1.18 | 32.16 | 31.70 | 4.17 | 1.36 | 1.89 | 2.00 | 0.4271 | -- | 3.96 | 2.93 | 59.08 | 18.88 | 0.2924 | -- |
ZimVie Inc | 453.38m | -54.86m | 456.31m | 2.60k | -- | 1.16 | -- | 1.01 | -2.04 | -13.27 | 16.84 | 14.29 | 0.3858 | 1.12 | 3.80 | 174,378.50 | -4.67 | -- | -5.43 | -- | 63.11 | 65.51 | -12.10 | -8.73 | 1.43 | -0.3884 | 0.3737 | -- | -1.26 | -16.08 | -19.50 | -- | -23.70 | -- |
Pacific Biosciences of California Inc | 188.87m | -400.38m | 497.37m | 796.00 | -- | 1.01 | -- | 2.63 | -1.50 | -1.50 | 0.7099 | 1.81 | 0.1125 | 2.05 | 6.69 | 237,275.10 | -23.85 | -16.19 | -26.63 | -17.81 | 26.01 | 37.35 | -211.99 | -136.21 | 7.14 | -22.46 | 0.6444 | -- | 56.29 | 20.59 | 2.39 | -- | 36.68 | -- |
Surmodics Inc | 120.82m | -1.40m | 555.73m | 376.00 | -- | 4.74 | 75.99 | 4.60 | -0.0955 | -0.0955 | 8.55 | 8.28 | 0.6597 | 2.09 | 5.64 | 321,332.40 | -0.7638 | -1.85 | -0.8909 | -2.18 | 74.02 | 82.93 | -1.16 | -2.98 | 3.22 | -4.46 | 0.1999 | -- | 32.65 | 10.27 | 94.37 | -- | -27.02 | -- |
Quanterix Corp | 129.33m | -39.71m | 558.03m | 441.00 | -- | 1.66 | -- | 4.31 | -1.04 | -1.04 | 3.40 | 8.77 | 0.3078 | 2.37 | 4.60 | 293,265.30 | -9.45 | -15.96 | -10.30 | -17.66 | 57.42 | 52.79 | -30.71 | -53.79 | 8.99 | -- | 0.00 | -- | 15.96 | 26.60 | 66.56 | -- | 20.07 | -- |
Paragon 28 Inc | 235.44m | -59.07m | 573.67m | 430.00 | -- | 3.91 | -- | 2.44 | -0.7132 | -0.7132 | 2.84 | 1.76 | 0.7703 | 0.6049 | 6.63 | 547,539.60 | -19.33 | -- | -23.48 | -- | 76.67 | -- | -25.09 | -- | 1.70 | -5.30 | 0.4295 | -- | 19.30 | -- | 28.94 | -- | -- | -- |
Iradimed Corp | 69.48m | 18.64m | 607.90m | 148.00 | 32.80 | 7.63 | 31.23 | 8.75 | 1.46 | 1.46 | 5.45 | 6.29 | 0.8109 | 1.55 | 6.03 | 469,485.30 | 21.76 | 13.16 | 23.85 | 14.58 | 77.21 | 76.55 | 26.83 | 21.46 | 8.25 | 144.05 | 0.00 | 68.13 | 23.00 | 16.59 | 34.02 | 22.22 | 97.77 | -- |
Orthofix Medical Inc | 771.65m | -120.49m | 608.35m | 1.63k | -- | 1.13 | -- | 0.7884 | -3.21 | -3.21 | 20.55 | 14.35 | 0.8654 | 1.17 | 6.49 | 472,245.40 | -13.51 | -8.88 | -16.22 | -10.96 | 67.18 | 72.37 | -15.62 | -9.28 | 1.13 | -4.94 | 0.2005 | -- | 62.06 | 10.51 | -666.60 | -- | 30.01 | -- |
AxoGen Inc | 173.48m | -16.54m | 617.12m | 426.00 | -- | 6.45 | -- | 3.56 | -0.3829 | -0.3829 | 4.01 | 2.18 | 0.9117 | 1.62 | 7.43 | 407,237.10 | -8.69 | -13.92 | -9.93 | -15.84 | 76.98 | 79.74 | -9.53 | -20.28 | 2.32 | -2.94 | 0.3297 | -- | 14.74 | 13.63 | 24.98 | -- | 17.70 | -- |
Simulations Plus Inc | 66.98m | 9.65m | 624.84m | 192.00 | 65.88 | 3.45 | 44.19 | 9.33 | 0.474 | 0.474 | 3.29 | 9.04 | 0.3603 | -- | 5.57 | 348,843.80 | 5.19 | 7.20 | 5.49 | 7.61 | 72.53 | 77.61 | 14.40 | 21.29 | -- | -- | 0.00 | 45.70 | 10.52 | 14.96 | -20.20 | 6.02 | 12.91 | 0.8548 |
Jin Medical International Ltd | 20.13m | 2.91m | 638.71m | 245.00 | 218.88 | 24.34 | 209.57 | 31.74 | 0.0186 | 0.0186 | 0.1292 | 0.1676 | 0.5576 | 2.38 | 4.22 | 82,143.59 | 7.80 | 12.81 | 11.27 | 20.92 | 34.73 | 33.58 | 13.99 | 14.60 | 2.27 | -- | 0.2702 | 0.00 | 3.29 | -1.07 | 6.34 | -4.80 | -9.50 | -- |
SI-Bone Inc | 150.71m | -40.85m | 641.67m | 344.00 | -- | 3.88 | -- | 4.26 | -1.00 | -1.00 | 3.70 | 3.97 | 0.6586 | 1.54 | 6.67 | 438,107.60 | -17.85 | -27.88 | -19.57 | -30.94 | 77.69 | 85.03 | -27.10 | -51.09 | 8.12 | -- | 0.18 | -- | 30.52 | 20.19 | 29.25 | -- | 52.62 | -- |
Cytek Biosciences Inc | 197.71m | -17.56m | 669.36m | 645.00 | -- | 1.72 | -- | 3.39 | -0.1327 | -0.1327 | 1.49 | 2.96 | 0.392 | 1.54 | 4.19 | 292,470.40 | -3.48 | -- | -3.89 | -- | 54.97 | -- | -8.88 | -- | 6.38 | -- | 0.0083 | -- | 17.67 | -- | -571.58 | -- | -- | -- |
Mesa Laboratories Inc | 223.71m | -250.31m | 695.46m | 736.00 | -- | 4.61 | -- | 3.11 | -46.43 | -46.43 | 41.43 | 27.87 | 0.4131 | 2.51 | 6.29 | 303,956.50 | -46.23 | -9.20 | -50.62 | -9.88 | 62.27 | 60.60 | -111.89 | -28.33 | 1.37 | 1.33 | 0.5848 | -- | -1.32 | 15.95 | -27,438.28 | -- | 15.26 | 0.00 |
Orthopediatrics Corp | 175.07m | -25.12m | 695.92m | 247.00 | -- | 1.87 | -- | 3.98 | -1.10 | -1.10 | 7.65 | 15.33 | 0.4045 | 0.4286 | 4.61 | 708,793.50 | -5.80 | -5.40 | -6.43 | -5.93 | 74.62 | 75.09 | -14.35 | -15.92 | 1.96 | -44.23 | 0.0261 | -- | 21.62 | 20.91 | -1,767.25 | -- | 28.29 | -- |
Standard Biotools Inc | 136.30m | -164.66m | 746.02m | 534.00 | -- | 1.46 | -- | 5.47 | -0.9018 | -0.9018 | 0.6606 | 1.37 | 0.2561 | 2.25 | 5.73 | 255,243.50 | -22.29 | -28.17 | -26.55 | -33.60 | 46.67 | 51.58 | -87.05 | -74.85 | 3.53 | -- | 0.0974 | -- | 8.57 | -1.20 | 60.73 | -- | 50.06 | -- |
Holder | Shares | % Held |
---|---|---|
Armistice Capital LLCas of 31 Mar 2024 | 3.70m | 9.86% |
Rubric Capital Management LPas of 31 Mar 2024 | 3.67m | 9.77% |
Engine Capital Management LPas of 31 Mar 2024 | 3.04m | 8.09% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 2.83m | 7.55% |
Morgan Stanley & Co. LLCas of 31 Mar 2024 | 2.70m | 7.20% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.95m | 5.20% |
Paradigm Capital Management, Inc.as of 31 Mar 2024 | 1.95m | 5.19% |
Newtyn Management LLCas of 31 Mar 2024 | 1.27m | 3.39% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 1.07m | 2.84% |
Boone Capital Management LLCas of 31 Mar 2024 | 974.50k | 2.60% |